North America Botulinum Toxin Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	115 Pages	Triton Market Research	August, 2023	TRTN18135582

Best Price Guarantee
Price	from $1,500
Length	115 Pages
Publisher	Triton Market Research
Published Date	August, 2023
SKU	TRTN18135582

North America Botulinum Toxin Market 2023-2030

Market Outlook

Triton Market Research’s report states that North America botulinum toxin market is deemed to garner a compound annual growth rate of 9.78% over the forecasting years from 2023 to 2030. Canada and the United States are studied in the given region.

In the US, the growing popularity of cosmetic treatments and product approvals widens the scope of the botulinum toxin market. For instance, Evolus Inc garnered approval from the FDA for Jeuveau for the temporary enhancement of the appearance of moderate to severe glabellar lines in adults linked to the activity of the corrugator and procerus muscles. Moreover, the FDA sanctioned the specific indications requiring Botox injections to address frown lines, crow’s feet, and horizontal forehead lines.

Furthermore, according to estimates, Canada hosts a skilled workforce of aesthetic surgeons who play a key role in the botulinum toxin market’s expansion. Besides this, strategic initiatives have elevated the market scope in recent years. For instance, Evolus Inc and Clarion Medical Technologies, a prominent Canadian provider of medical and aesthetic equipment and consumables, launched the shipment of Nuceiva (prabotulinumtoxinA) to Canada.
Competitive Outlook
The major enterprises in the botulinum toxin market are Evolus Inc, Galderma SA, Ipsen Pharma, US WorldMeds LLC, and AbbVie Inc.

1. North America Botulinum Toxin Market - Summary
2. Industry Outlook: 2.1. Impact Analysis On The Botulinum Toxin Market; 2.1.1. Covid-19 Impact; 2.2. Key Insights; 2.2.1. Growing Demand For Non-invasive Cosmetic Procedures; 2.2.2. Surge In Demand For Botulinum Toxin Among Millennials And Gen-z; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Regulatory Framework; 2.5. Key Market Strategies; 2.5.1. Product Launches; 2.5.2. Collaborations; 2.5.3. Business Expansions & Divestitures; 2.5.4. Acquisitions; 2.6. Market Drivers; 2.6.1. Surge In Demand For Aesthetic Procedures; 2.6.2. Rise In Geriatric Population; 2.7. Market Challenges; 2.7.1. Limited Reimbursement Policies Supporting Cosmetic Procedures; 2.7.2. Adverse Effects Of Botulinum Toxin; 2.7.3. Emerging Problem Of Botulinum Toxin Type A Resistance; 2.8. Market Opportunities; 2.8.1. Expansion Of Botulinum Toxin Into Therapeutic Applications; 2.8.2. Rising Medical Tourism; 2.9. Analyst Perspective
3. North America Botulinum Toxin Market Outlook - By Product Type: 3.1. Type A Botulinum Toxin; 3.2. Type B Botulinum Toxin
4. North America Botulinum Toxin Market Outlook - By Gender: 4.1. Women; 4.2. Men
5. North America Botulinum Toxin Market Outlook - By Application: 5.1. Aesthetic; 5.1.1. Crow’s Feet; 5.1.2. Forehead Lines; 5.1.3. Frown Lines/Glabellar; 5.1.4. Square Jaw/Masseter; 5.1.5. Other Aesthetic Applications; 5.2. Medical; 5.2.1. Chronic Migraine; 5.2.2. Muscle Spasm; 5.2.3. Overactive Bladder; 5.2.4. Hyperhidrosis; 5.2.5. Other Medical Applications
6. North America Botulinum Toxin Market Outlook - By End-user: 6.1. Specialty And Dermatology Clinics; 6.2. Hospitals And Clinics; 6.3. Other End-users
7. North America Botulinum Toxin Market – By Country Outlook: 7.1. North America; 7.1.1. Market By Product Type; 7.1.2. Market By Gender; 7.1.3. Market By Application; 7.1.3.1. Market By Aesthetic; 7.1.3.2. Market By Medical; 7.1.4. Market By End-user; 7.1.5. Country Analysis; 7.1.5.1. United States; 7.1.5.1.1. United States Botulinum Toxin Market Forecast & Prospects; 7.1.5.2. Canada; 7.1.5.2.1. Canada Botulinum Toxin Market Forecast & Prospects
8. Competitive Landscape: 8.1. Abbvie Inc; 8.1.1. Overview; 8.1.2. Product Portfolio; 8.1.3. Key Strengths; 8.1.4. Key Challenges; 8.2. Evolus Inc; 8.2.1. Overview; 8.2.2. Product Portfolio; 8.2.3. Key Strengths; 8.2.4. Key Challenges; 8.3. Medytox Inc; 8.3.1. Overview; 8.3.2. Product Portfolio; 8.3.3. Key Strengths; 8.3.4. Key Challenges; 8.4. Lanzhou Institute Of Biological Products Co Ltd; 8.4.1. Overview; 8.4.2. Product Portfolio; 8.4.3. Key Strengths; 8.4.4. Key Challenges; 8.5. Daewoong Pharmaceutical Co Ltd; 8.5.1. Overview; 8.5.2. Product Portfolio; 8.5.3. Key Strengths; 8.5.4. Key Challenges; 8.6. Galderma Sa; 8.6.1. Overview; 8.6.2. Product Portfolio; 8.6.3. Key Strengths; 8.6.4. Key Challenges; 8.7. Ipsen Pharma; 8.7.1. Overview; 8.7.2. Product Portfolio; 8.7.3. Key Strengths; 8.7.4. Key Challenges; 8.8. Hugel Inc; 8.8.1. Overview; 8.8.2. Product Portfolio; 8.8.3. Key Strengths; 8.8.4. Key Challenges; 8.9. Candela Medical Corporation; 8.9.1. Overview; 8.9.2. Product Portfolio; 8.9.3. Key Strengths; 8.9.4. Key Challenges; 8.10. Merz Pharma Gmbh & Co Kgaa; 8.10.1. Overview; 8.10.2. Product Portfolio; 8.10.3. Key Strengths; 8.10.4. Key Challenges; 8.11. Revance Therapeutics Inc; 8.11.1. Overview; 8.11.2. Product Portfolio; 8.12. Us Worldmeds Llc; 8.12.1. Overview; 8.12.2. Product Portfolio
9. Research Methodology & Scope: 9.1. Research Scope & Deliverables; 9.2. Sources Of Data; 9.3. Research Methodology
List Of Tables: Table 1: North America Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million); Table 2: North America Regulatory Framework For Botulinum Toxin; Table 3: List Of Product Launches; Table 4: List Of Collaborations; Table 5: List Of Business Expansions & Divestitures; Table 6: List Of Acquisitions; Table 7: Example Of Commercially Available Botulinum Toxin Type A For Aesthetic Procedures; Table 8: North America Botulinum Toxin Market, By Product Type, 2023-2030 (In $ Million); Table 9: North America Botulinum Toxin Market, By Gender, 2023-2030 (In $ Million); Table 10: North America Botulinum Toxin Market, By Application, 2023-2030 (In $ Million); Table 11: North America Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Table 12: North America Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Table 13: North America Botulinum Toxin Market, By End-user, 2023-2030 (In $ Million); Table 14: North America Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million)
List Of Figures: Figure 1: North America Botulinum Toxin Market, By Product Type, 2022 & 2030 (In %); Figure 2: North America Botulinum Toxin Market, By Type A Botulinum Toxin, 2023-2030 (In $ Million); Figure 3: North America Botulinum Toxin Market, By Type B Botulinum Toxin, 2023-2030 (In $ Million); Figure 4: North America Botulinum Toxin Market, By Gender, 2022 & 2030 (In %); Figure 5: North America Botulinum Toxin Market, By Women, 2023-2030 (In $ Million); Figure 6: North America Botulinum Toxin Market, By Men, 2023-2030 (In $ Million); Figure 7: North America Botulinum Toxin Market, By Application, 2022 & 2030 (In %); Figure 8: North America Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Figure 9: North America Botulinum Toxin Market, By Aesthetic, 2022 & 2030 (In %); Figure 10: North America Botulinum Toxin Market, By Crow’s Feet, 2023-2030 (In $ Million); Figure 11: North America Botulinum Toxin Market, By Forehead Lines, 2023-2030 (In $ Million); Figure 12: North America Botulinum Toxin Market, By Frown Lines/Glabellar, 2023-2030 (In $ Million); Figure 13: North America Botulinum Toxin Market, By Square Jaw/Masseter, 2023-2030 (In $ Million); Figure 14: North America Botulinum Toxin Market, By Other Aesthetic Applications, 2023-2030 (In $ Million); Figure 15: North America Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Figure 16: North America Botulinum Toxin Market, By Medical, 2022 & 2030 (In %); Figure 17: North America Botulinum Toxin Market, By Chronic Migraine, 2023-2030 (In $ Million); Figure 18: North America Botulinum Toxin Market, By Muscle Spasm, 2023-2030 (In $ Million); Figure 19: North America Botulinum Toxin Market, By Overactive Bladder, 2023-2030 (In $ Million); Figure 20: North America Botulinum Toxin Market, By Hyperhidrosis, 2023-2030 (In $ Million); Figure 21: North America Botulinum Toxin Market, By Other Medical Applications, 2023-2030 (In $ Million); Figure 22: North America Botulinum Toxin Market, By End-user, 2022 & 2030 (In %); Figure 23: North America Botulinum Toxin Market, By Specialty And Dermatology Clinics, 2023-2030 (In $ Million); Figure 24: North America Botulinum Toxin Market, By Hospitals And Clinics, 2023-2030 (In $ Million); Figure 25: North America Botulinum Toxin Market, By Other End-users, 2023-2030 (In $ Million); Figure 26: North America Botulinum Toxin Market, By Country Outlook, 2022 & 2030 (In %); Figure 27: United States Botulinum Toxin Market 2023-2030 (In $ Million); Figure 28: Canada Botulinum Toxin Market 2023-2030 (In $ Million)